When treated, AF in HCM is associated with low disease-related mortality, no different than for patients without AF, and is not a major contributor to heart failure morbidity or arrhythmic sudden death.

Atrial fibrillation in hypertrophic cardiomyopathy does not significantly increase disease-related mortality or sudden death when treated, though it carries a risk of embolic stroke supporting early anticoagulation.